Skip to content
Press Release
FEATURED | September 11, 2025

Jason Chambers Headlines the Melanoma Research Fou...

Superyacht Captain, TV Personality, Melanoma Patient and Advocate Poised to Emcee Event Honoring the Melanoma Community  New York City, NY (September 11, 2025) – The...

4 Minute Read
December 20, 2017

Targeting genomic mechanisms of resistance to immu...

Immunotherapies, such as CTLA-4 or PD-1 inhibitors, have revolutionized the treatment of metastatic melanoma patients. However, a key challenge to optimize the opportunity ...

2 Minute Read
December 20, 2017

The genetic evolution of uveal melanoma

Uveal melanoma is a type of melanoma that occurs in the eye as opposed to the most common presentations of melanoma, which occur on the skin. A diagnosis of uveal ...

2 Minute Read
December 20, 2017

Comprehensive Profiling of Immune Checkpoint Inhib...

Immune therapies termed “immune checkpoint inhibitors” remove key “brakes” on immune cells. These treatments lead to long-term responses and cures in some patients ...

2 Minute Read

Oct 16, 2025 ET

Ask the Expert: Mucosal Melanoma – Current and Emerging Treatments, Research and Patient Perspectives

Oct 16, 2025 ET

5th Annual #GetNakedJax

Oct 18, 2025 ET

San Diego Miles for Melanoma 5K

Oct 25, 2025 ET

CURE OM Global Science Meeting

Oct 30, 2025 ET

Ask The Expert: Minimal Residual Disease Testing in Melanoma Management

Oct 30, 2025 ET

24th Annual New York Gala

Nov 02, 2025 ET

Atlanta Miles for Melanoma 5K

Explore Events